JCI - Citations to Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Citations to this article

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

L C Miller, … , A C Steere, C A Dinarello

Published September 1, 1992
Citation Information: J Clin Invest. 1992;90(3):906-912. https://doi.org/10.1172/JCI115966.

View: Text | PDF

Research Article

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Text
PDF

Abstract

Lyme arthritis is one of the few forms of chronic arthritis in which the cause is known with certainty. Because cytokines are thought to contribute to the pathogenesis of chronic arthritis, we investigated the effect of the Lyme disease spirochete, Borrelia burgdorferi, on the gene expression and synthesis of IL-1 beta and the IL-1 receptor antagonist (IL-1ra) in human peripheral blood mononuclear cells. Live B. burgdorferi induced fivefold more IL-1 beta than IL-1 alpha and sevenfold more IL-1 beta than IL-1ra; LPS or sonicated B. burgdorferi induced similar amounts of all three cytokines. This preferential induction of IL-1 beta was most dramatic in response to a low passage, virulent preparation of B. burgdorferi vs. three high passage avirulent strains. No difference in induction of IL-1ra was seen between these strains. The marked induction of IL-1 beta was partially diminished by heat-treatment and abrogated by sonication; IL-1ra was not affected. This suggested that a membrane component(s) accounted for the preferential induction of IL-1 beta. However, recombinant outer surface protein beta induced little IL-1 beta. By 4 h after stimulation, B. burgdorferi induced sixfold more IL-1 beta protein than LPS. In contrast to LPS-induced IL-1 beta mRNA which reached maximal accumulation after 3 h, B. burgdorferi-induced IL-1 beta mRNA showed biphasic elevations at 3 and 18 h. B. burgdorferi-induced IL-1ra mRNA peaked at 12 h, whereas LPS-induced IL-1ra mRNA peaked at 9 h. IL-1 beta synthesis increased in response to increasing numbers of spirochetes, whereas IL-1ra synthesis did not. The preferential induction by B. burgdorferi of IL-1 beta over IL-1ra is an example of excess agonist over antagonist synthesis induced by a microbial pathogen, and may contribute to the destructive lesion of Lyme arthritis.

Authors

L C Miller, S Isa, E Vannier, K Georgilis, A C Steere, C A Dinarello

Total citations by year

Year:	2024	2021	2016	2015	2014	2011	2010	2009	2008	2006	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1991	Total
Citations:	1	1	3	2	1	1	1	1	2	1	1	3	1	2	1	5	6	3	4	8	5	1	54

Citation information

Citations to this article (54)

Title and authors	Publication	Year
A comprehensive genetic map of cytokine responses in Lyme borreliosis. Botey-Bataller J, Vrijmoeth HD, Ursinus J, Kullberg BJ, van den Wijngaard CC, Ter Hofstede H, Alaswad A, Gupta MK, Roesner LM, Huehn J, Werfel T, Schulz TF, Xu CJ, Netea MG, Hovius JW, Joosten LAB, Li Y	Nature Communications	2024
Innate and Th1/Th17 adaptive immunity in acute and convalescent Brazilian borreliosis disease. Bonoldi VLN, Yoshinari NH, Aniz PAEA, Pereira RMR	The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases	2021
Autophagy suppresses host adaptive immune responses toward Borrelia burgdorferi K Buffen, M Oosting, Y Li, TD Kanneganti, MG Netea, LA Joosten	Journal of leukocyte biology	2016
Textbook of Pediatric Rheumatology E Silverman, J Buyon, E Jaeggi	Textbook of Pediatric Rheumatology	2016
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection A Badawi	Infectious Diseases and Therapy	2016
Lyme: inflammation, oxidative stress, and mitochondrial dysfunction BN Peacock, TB Gherezghiher, JD Hilario, GH Kellermann	Redox Biology	2015
Interferon-α curbs production of interleukin-22 by human peripheral blood mononuclear cells exposed to live Borrelia burgdorferi A Berner, M Bachmann, J Pfeilschifter, P Kraiczy, H Mühl	Journal of Cellular and Molecular Medicine	2015
Innate immunity networks during infection with Borrelia burgdorferi M Oosting, K Buffen, JW van der Meer, MG Netea, LA Joosten	Critical Reviews in Microbiology	2014
LYME DISEASE HI Huppertz, F Dressler	Textbook of Pediatric Rheumatology	2011
Early Production of IL-22 but Not IL-17 by Peripheral Blood Mononuclear Cells Exposed to live Borrelia burgdorferi: The Role of Monocytes and Interleukin-1 M Bachmann, K Horn, I Rudloff, I Goren, M Holdener, U Christen, N Darsow, KP Hunfeld, U Koehl, P Kind, J Pfeilschifter, P Kraiczy, H Mühl, J Coburn	PLoS pathogens	2010
The Urokinase Receptor (uPAR) Facilitates Clearance of Borrelia burgdorferi JW Hovius, MF Bijlsma, GJ van der Windt, WJ Wiersinga, BJ Boukens, J Coumou, A Oei, R Beer, AF de Vos, C Veer, AP van Dam, P Wang, E Fikrig, MM Levi, JJ Roelofs, T der Poll, L Hu	PLoS pathogens	2009
Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi G Wang, MM Petzke, R Iyer, H Wu, I Schwartz	Journal of immunology (Baltimore, Md. : 1950)	2008
Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease P Rao, GC Reddy, AS Kanagasabapathy	Indian Journal of Clinical Biochemistry	2008
TLR2 expression in relation to IL-6 and IL-1beta and their natural regulators production by PMN and PBMC in patients with Lyme disease E Jablonska, M Marcinczyk	Mediators of Inflammation	2006
‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic? WT Harvey, P Salvato	Medical Hypotheses	2003
Cytokines and juvenile idiopathic arthritis P Woo	Current Rheumatology Reports	2002
A role for peripheral blood fibrocytes in Lyme disease? DJ Grab, M Salim, J Chesney, R Bucala, HN Lanners	Medical Hypotheses	2002
The balance between IL-1 and IL-1Ra in disease William P Arend	Cytokine & Growth Factor Reviews	2002
The importance of interleukin 1beta in Helicobacter pylori associated disease EM El-Omar	Gut	2001
Cytokine Inhibitors K Lipson, L Sun, C Liang, G McMahon	Cytokine Inhibitors	2000
Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible to Staphylococcus epidermidis Biomaterial-Associated Infection than Are Wild-Type Mice RN Moore, JJ Boelens, T van der Poll, SA Zaat, JL Murk, JJ Weening, J Dankert	Infection and immunity	2000
Borrelia burgdorferi induces matrix metalloproteinases by neural cultures G Perides, LM Tanner-Brown, MA Eskildsen, MS Klempner	Journal of Neuroscience Research	1999
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist CA Dinarello	International Reviews of Immunology	1998
Interleukin-1beta, Interleukin-18, and the Interleukin-1beta Converting Enzymea CA Dinarello	Annals of the New York Academy of Sciences	1998
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology WP Arend, M Malyak, CJ Guthridge, C Gabay	Annual Review of Immunology	1998
In vitro conversion ofBorrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium Ø Brorson, SH Brorson	Infection	1998
4 Cytokines in juvenile chronic arthritis P Woo	Baillière's Clinical Rheumatology	1998
LYME DISEASE:A Review of Aspects of Its Immunology and Immunopathogenesis LH Sigal	Annual Review of Immunology	1997
Interleukin-1 CA Dinarello	Cytokine & Growth Factor Reviews	1997
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis J Anguita, R Roth, S Samanta, RJ Gee, SW Barthold, M Mamula, E Fikrig	Infection and immunity	1997
A Pilot Study of the Predictive Value of Plasma Tumor Necrosis Factor α. and Interleukin 1β forStreptococcus pneumoniaeBacteremia in Febrile Children RT Strait, RM Ruddy, LR Friedland, KM Duncan, RW Wilmott	Academic Emergency Medicine	1997
Levels of Endogenous lnterleukin-1, Interleukin-6, and Tumor Necrosis Factor in Congenic Mice Infected with Borrelia garinii H Isogai, K Kimura, S Hayashi, T Kubota, N Fujii, T Nishikawa, S Kotake, E Isogai	Microbiology and Immunology	1997
Host-pathogen interactions in the immunopathogenesis of Lyme disease L T Hu, M S Klempner	Journal of Clinical Immunology	1997
Immunity to Lyme disease: protection, pathology and persistence KP Seiler, JJ Weis	Current Opinion in Immunology	1996
Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis J Oksi, J Savolainen, J Pène, J Bòusquet, P Laippala, MK Viljanen	Infection and immunity	1996
Prednisolone reduces experimental arthritis, and inflammatory tissue destruction in scid mice infected with borrelia burgdorferi U Hurtenbach, E Böggemeyer, T Stehle, C Museteanu, ED Pozo, MM Simon	International Journal of Immunopharmacology	1996
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology KP Seiler, Z Vavrin, E Eichwald, JB Hibbs, JJ Weis	Infection and immunity	1995
Fetal outcome in murine Lyme disease RM Silver, L Yang, RA Daynes, DW Branch, CM Salafia, JJ Weis	Infection and immunity	1995
Blocking interleukin-1 in sepsis CA Dinarello	Journal of Endotoxin Research	1995
Cytokines: Interleukins and Their Receptors R Kurzrock, M Talpaz		1995
Cytokine Antagonists in Infectious and Inflammatory Disorders A Catania, MG Manfredi, L Airaghi, G Ceriani, A Gandino, JM Lipton	Annals of the New York Academy of Sciences	1994
Is there a Role for Interleukin-1 Blockade in Intravenous Immunoglobulin Therapy? CA Dinarello	Immunological Reviews	1994
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway Y Ma, KP Seiler, KF Tai, L Yang, M Woods, JJ Weis	Infection and immunity	1994
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA KF Tai, Y Ma, JJ Weis	Infection and immunity	1994
Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes E Caron, T Peyrard, S Köhler, S Cabane, JP Liautard, J Dornand	Infection and immunity	1994
Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification JJ Weis, Y Ma, LF Erdile	Infection and immunity	1994
Response of soluble IL-2 receptor, interleukin-2 and interleukin-6 in patients with positive and negativeBorrelia burgdorferi serology I Nilsson, M Alves, L Nässberger	Infection	1994
Interleukin-8 and Related Chemotactic Cytokines M Baggiolini, B Moser, I Clark-Lewis	Chest	1994
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties Y Ma, JJ Weis	Infection and immunity	1993
Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture RJ Shoberg, DD Thomas	Infection and immunity	1993
Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis LC Miller, EA Lynch, S Isa, CA Dinarello, JW Logar, AC Steere	The Lancet	1993
The Role of Interleukin-1 in Disease FH Epstein, CA Dinarello, SM Wolff	New England Journal of Medicine	1993
2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.	Annals of the rheumatic diseases	1993
Lyme Borreliosis DA Holt, NJ Pattani, JT Sinnott, E Bradley	Infection Control and Hospital Epidemiology	1991

Citations to this article

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Abstract

Authors

Total citations by year

Citations to this article (54)

Sign up for email alerts